Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases
Authors:
- 24 March 2006
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 155 (2) , 451-454
Abstract
Nonmelanoma skin cancer represents a significant cause of morbidity in organ transplant recipients (OTRs). Cutaneous malignancies, mainly invasive squamous cell carcinoma and its precursor actinic keratosis (AK), appear approximately 5-10 years after organ transplantation. Impaired wound healing and high recurrence rates in immunocompromised patients treated with destructive therapies such as cryosurgery or topical 5-fluorouracil represent frequently known complications. To evaluate the safety and efficacy of imiqimod 5% in the treatment of AKs in OTRs. Six OTRs (two kidney, two heart, one lung and one liver) with extensive AKs were treated with imiquimod 5% cream two to three times weekly in an open-label uncontrolled, nonrandomized pilot study. In five of six patients treated with imiquimod 5% cream all AK lesions were cleared after 12-16 weeks. One patient showed partial response. Local adverse events at the site of application included erythema, oedema and mild erosion. No wound infection or scarring was observed in any of these patients. All graft-related laboratory parameters were stable during and after treatment. Immunosuppressive therapy remained unchanged throughout the treatment. These results suggest that imiquimod 5% cream may be useful for the local treatment of precancerous AK lesions in OTRs.Keywords
This publication has 13 references indexed in Scilit:
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Human Papillomavirus Infection and Skin Cancer Risk in Organ Transplant RecipientsJournal of Investigative Dermatology Symposium Proceedings, 2001
- Histologic features of actinic keratoses in solid organ transplant recipients and healthy controlsJournal of the American Academy of Dermatology, 2001
- Squamous Cell Carcinoma in Situ (Bowen's Disease) in Renal Transplant Patients Treated with 5% Imiquimod and 5% 5-Fluorouracil TherapyDermatologic Surgery, 2001
- Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six casesBritish Journal of Dermatology, 2001
- Skin diseases following organ transplantation—risk factors and new therapeutic approachesTransplantation Proceedings, 2001
- Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteinsGenes & Development, 2000
- Actinic KeratosisAmerican Journal of Clinical Dermatology, 2000
- Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantationJournal of the American Academy of Dermatology, 1995
- CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTSThe Lancet, 1984